A carregar...
NI-39 INITIAL EVALUATION OF AN ADENOSINE RECEPTOR AGONIST'S ABILITY TO TRANSIENTLY DISRUPT THE BLOOD BRAIN BARRIER (BBB) IN PATIENTS WITH IN NORMAL BRAINS
BACKGROUND: Regadenoson is an FDA approved adenosine receptor agonist which transiently disrupts the BBB in rodents allowing systemically administered high molecular weight dextran (MW 70kD) to enter brain parenchyma. This agent is used clinically for cardiac stress tests in patients unable to exerc...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218364/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou264.37 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|